Inactive Instrument

Insiders Cytori Therapeutics Inc Nasdaq

Equities

US23283K1051

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Plus Therapeutics, Inc. Appoints Pius Maliakal as Vice President of Clinical Operations	23-07-27	CI
Plus Therapeutics, Inc. Announces Selection of Rhenium Obisbemeda as International Non-Proprietary Name for 186RNL	22-10-26	CI
Plus Therapeutics, Inc. Announces Executive Changes	21-09-13	CI
Plus Therapeutics Announces Formation of Scientific Advisory Board	20-11-05	CI
Plus Therapeutics, Inc. Announces Brain Cancer Clinical Advisory Team	20-10-02	CI
Plus Therapeutics, Inc. Appoints Gregory Stein as Senior Vice President of Clinical Development	20-04-01	CI
Plus Therapeutics, Inc. Announces Executive Changes, Effective April 1, 2020	20-03-12	CI
Plus Therapeutics, Inc Announces Executive Changes	20-02-06	CI
Plus Therapeutics, Inc Changes to Its Board of Directors	20-02-06	CI
Plus Therapeutics Appoints Dr. An van Es-Johansson to Board of Directors	20-01-02	CI
Plus Therapeutics, Inc. Announces the Resignation of Ronald A. Martell as Member of the Board of Directors, Effective December 21, 2019	19-11-27	CI
Plus Therapeutics Appoints Desiree Smith as Corporate Controller and Principal Financial and Accounting Officer	19-11-08	CI
Plus Therapeutics, Inc. Announces Management Changes	19-08-09	CI
Cytori Therapeutics, Inc. has Changed its Name to Plus Therapeutics, Inc	19-07-29	CI
Cytori Therapeutics, Inc. Announces Executive Changes	19-07-05	CI
Cytori Therapeutics, Inc. Announces Management Changes	19-03-18	CI
Cytori Therapeutics, Inc. Announces Resignation of Gary Lyons as Member of the Board of Directors	19-02-01	CI
Cytori Therapeutics, Inc. Announces Resignation of John D. Harris as Vice President and General Manager of Cell Therapy	18-02-09	CI
Cytori Therapeutics, Inc. Announces Board Changes	18-01-29	CI
Cytori Therapeutics, Inc. Appoints Gregg Lapointe as an Independent Director	17-04-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cytori Therapeutics Inc Nasdaq

Equities

US23283K1051

Insiders

Filters